✦ LIBER ✦

A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy

✍ Scribed by Carolyn S Massey

Book ID: 116436380
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 258 KB
Volume: 8
Category: Article
ISSN: 1462-3889
DOI: 10.1016/j.ejon.2003.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerance of a scalp-coolin

Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy

✍ Christel Protière, Katrin Evans, Jacques Camerlo, Marie-Pierre d'Ingrado, Genevi 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 83 KB

A prospective, multicentre study to inve

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly

✍ Moises Mercado; Fatima Borges; Hakim Bouterfa; Tien-Chun Chang; Alberto Chervin; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Milestone - Multicentre lloprost Europea

Milestone - Multicentre lloprost European study on endangiitis: a controlled double-blind study to determine the efficacy of Iloprost, a stable PGI2-analogue, in patients with thromboangiitis obliterans (Buerger's disease)

✍ Schaefer, M. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A phase IV randomized, double-blind, pla

A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

One year efficacy and tolerability of cl

One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension — a multicentre open label study

📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 403 KB